Cost-effectiveness of Rifaximin treatment in patients with advanced fibrosis who maintain excessive alcohol consumption.
| dc.contributor.author | Khlghatyan, Davit | |
| dc.date.accessioned | 2021-10-06T22:00:42Z | |
| dc.date.available | 2021-10-06T22:00:42Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Khlghatyan, Davit. Cost-effectiveness of Rifaximin treatment in patients with advanced fibrosis who maintain excessive alcohol consumption.. Master thesis, University of Oslo, 2021 | |
| dc.identifier.uri | http://hdl.handle.net/10852/88784 | |
| dc.description.abstract | eng | |
| dc.language.iso | eng | |
| dc.subject | ||
| dc.title | Cost-effectiveness of Rifaximin treatment in patients with advanced fibrosis who maintain excessive alcohol consumption. | eng |
| dc.type | Master thesis | |
| dc.date.updated | 2021-10-06T22:00:42Z | |
| dc.creator.author | Khlghatyan, Davit | |
| dc.identifier.urn | URN:NBN:no-91399 | |
| dc.type.document | Masteroppgave | |
| dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/88784/1/DavitKhlghatyanTHESIS.pdf |